Related Experiment Video
Updated: Aug 9, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Gram-negative bacterial pneumonia: aetiology and management
Despoina Koulenti1, Jordi Rello
1Critical Care Department, Joan XXIII University Hospital, University Rovira y Virgili/Institut PereVirgili, Tarragona, Spain.
Current Opinion in Pulmonary Medicine
|April 4, 2006
Summary
Gram-negative pneumonia, especially hospital-acquired and ventilator-associated types, is increasingly caused by resistant bacteria like Pseudomonas aeruginosa. Early, targeted antibiotic therapy is crucial for patient survival.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Gram-negative bacteria are significant pathogens in hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
- Increasing resistance among Gram-negative bacteria poses a therapeutic challenge.
Purpose of the Study:
- To review recent clinical and investigational articles on Gram-negative pneumonia.
- To focus on hospital-acquired and ventilator-associated pneumonia.
Main Methods:
- Literature review of recent articles.
- Analysis of epidemiological trends and treatment strategies.
Main Results:
- High rates of Gram-negative infections, particularly Pseudomonas aeruginosa and Acinetobacter baumannii, in late-onset VAP.
- Increasing incidence of Gram-negative bacteria in community-acquired pneumonia (CAP) and early-onset VAP.
- Recommended initial broad-spectrum combination therapy for patients at risk of resistant pathogens, followed by de-escalation.
- Importance of adequate antibiotic dosing using pharmacodynamic/pharmacokinetic principles.
- Shorter treatment durations show promise; optimal duration remains under investigation.
- Vaccines and alternative approaches are being explored.
Conclusions:
- Rising resistance and a limited pipeline of new Gram-negative antibiotics are concerning.
- Prompt and effective antimicrobial treatment is vital for infection resolution and improved survival.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: